BiVictriX Therapeutics Plc (LON:BVX – Get Free Report)’s share price reached a new 52-week low on Wednesday . The stock traded as low as GBX 7 ($0.09) and last traded at GBX 8.50 ($0.11), with a volume of 538991 shares changing hands. The stock had previously closed at GBX 8.25 ($0.11).
BiVictriX Therapeutics Price Performance
The business’s fifty day moving average price is GBX 11.85 and its 200-day moving average price is GBX 11.59. The company has a market capitalization of £7.02 million, a P/E ratio of -212.50 and a beta of -0.60. The company has a current ratio of 4.40, a quick ratio of 7.49 and a debt-to-equity ratio of 8.81.
About BiVictriX Therapeutics
BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia, as well as develops BVX002 and BVX003 for various blood cancers and solid tumours.
Featured Stories
- Five stocks we like better than BiVictriX Therapeutics
- Upcoming IPO Stock Lockup Period, Explained
- Lumen: Among Top Performers Last Month, Still Has Warning Signs
- Conference Calls and Individual Investors
- Baidu’s Strong Quarter Proves a Smart Pick for Michael Burry
- Trading Halts Explained
- Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy
Receive News & Ratings for BiVictriX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiVictriX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
